Benchmark maintains Buy on CSX, raises target to $54

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Benchmark analyst Nathan P. Martin maintains a Buy rating on CSX and raises the price target to $54 from $48, joining other firms like Susquehanna and JP Morgan in increasing their targets.

powered bylight_fuzz_icon
44969614

*this image is generated using AI for illustrative purposes only.

Benchmark analyst Nathan P. Martin has maintained a Buy rating on CSX (NASDAQ:CSX) and raised the price target to $54 from $48. This adjustment reflects continued confidence in the freight transportation sector, where CSX operates a major rail network across the Eastern United States.

The revised target from Benchmark aligns with a broader trend of positive valuation updates from major financial firms. Susquehanna analyst Bascome Majors recently upgraded the stock from Neutral to Positive, setting a price target of $58, up from $50.

Other firms have also adjusted their targets upward based on recent analyses. JP Morgan, Wells Fargo, Baird, Citigroup, and TD Cowen have all increased their price objectives, suggesting potential upside from current trading levels.

Firm Analyst Rating Previous Target New Target
Benchmark Nathan P. Martin Buy $48 $54
Susquehanna Bascome Majors Positive $50 $58
JP Morgan Brian Ossenbeck Overweight $48 $56
Wells Fargo Christian Wetherbee Overweight $50 $54
Baird Dan Moore Outperform $49 $53
Citigroup Ariel Rosa Neutral $46 $53
TD Cowen Jason Seidl Buy $45 $46
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific operational metrics or market conditions are driving the consensus among analysts to raise price targets?

How might potential changes in freight demand or economic conditions impact CSX's ability to meet these elevated expectations?

What are the key risks or challenges CSX could face that might hinder its growth trajectory in the coming quarters?

like17
dislike

Morgan Stanley raises CSX price target to $32

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Morgan Stanley analyst Ravi Shanker maintains an Underweight rating on CSX but raises the price target to $32 from $30, reflecting a revised valuation outlook.

powered bylight_fuzz_icon
44897982

*this image is generated using AI for illustrative purposes only.

Morgan Stanley analyst Ravi Shanker has maintained an Underweight rating on CSX (NASDAQ: CSX) while raising the price target to $32 from $30. The revised target indicates a shift in valuation expectations despite the continued cautious stance.

Rating and Price Target Details

The Underweight rating suggests that the stock is expected to underperform relative to the broader market or sector benchmarks. The price target increase to $32 implies a specific upside potential based on the firm's analysis.

Metric Value
Rating Underweight
Previous Price Target $30
New Price Target $32

Analyst Perspective

Ravi Shanker's recommendation highlights a nuanced view, balancing a higher price target with a conservative rating. This dual adjustment signals updated financial modeling or market conditions affecting CSX's projected performance.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove the price target increase despite the maintained Underweight rating?

How might CSX's upcoming earnings report influence Morgan Stanley's future stance on the stock?

What market conditions or sector trends could lead to a potential rating upgrade for CSX?

like19
dislike

More News on CSX Corp